Exam 3 Flashcards
GI Diagnostics: Esophagogastroduodenoscopy (EGD)
Purpose (2)
Nursing Care (3)
Purpose
* Viewing of the upper GI tract from the esophagus to the upper duodenum
* Used to find upper GI bleeding, PUD, biopsy
Nursing Care
* Keep NPO until gag reflex returns
* Monitor for perforation (pain, bleeding, fever)
* NPO 6-8 hr prior to procedure
GI Diagnostics: Magnetic resonance enterography (MRE)
Purpose
Patient Education (3)
Purpose
- visualize bowel (lumen, wall, mesentery, and surrounding abdominal organs) in pts w/ chronic IBD
Patient education
- NPO 4-6 hrs before test
- Must drink large amount of contrast medium (may cause abdominal discomfort and diarrhea so allowed to use restroom after)
- Patient will lie prone and get two subQ glucagon doses to slow bowel activity and motility
GI Diagnostics: Purposes
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Abdominal ultrasound
- Abdominal X-ray
Endoscopic retrograde cholangiopancreatography (ERCP)
* Visualize the liver, gallbladder, bile ducts, and pancreas
Abdominal ultrasound
* Visualize gallbladder, biliary system, liver, spleen, and pancreas
Abdominal X-ray
* Visualize bowel obstruction and perforation
GI Diagnostics: Purposes
- MRI (2)
- Fibrotic endoscopy
- Angiography
MRI
* Identify tumors, abscesses, hemorrhages, and vascular abnormalities
* shows fluid and gas in small intestine and absence of gas in colon if small intestine obstruction
Fibrotic endoscopy
* Direct visualization and evaluation of GI tract
Angiography
* Evaluate status of GI circulation and control bleeding
GI diagnostics: Purposes
- GI bleeding scan (2)
- Hepatobiliary scan (2)
GI bleeding scan
* Evaluate presence and location of active GI bleed
* Assess need for arteriogram
Hepatobiliary scan
* Visualize the gallbladder
* Determine patency of the biliary
system
Lab tests for Peptic Ulcer Disease
Urea Breath Test (3)
Stool Antigen Test
Serologic Test
Urea breath test
* Exhales in collection container (baseline) after NPO
* Swallow capsule, liquid or pudding w/ urea and special carbon atom
* patient exhales after a few minutes and if CO2 released, bacterium is present
Stool antigen test
- tool sample tested for H. pylori; positive if occult blood
Serologic testing (most common but others more accurate)
- detects H pylori via antibody assays
Types of Mechanical Intestinal Obstructions (6)
- Ulcerative colitis (adhesions/scar tissue outside bowel)
- Crohn’s disease (strictures in bowel wall)
- Tumors and hernias in intestinal lumen
- Fecal impactions
- Intussusception (telescoping of intestine into itself)
- volvulus (twisting)
Types of non-mechanical intestinal obstructions (3)
- Postoperative ileus r/t handling bowel in surgery, peritonitis
- Intestinal ischemia ileus r/t thrombosis or embolism (risk for sepsis)
- Oral opioid analgesic
Signs of small bowel obstruction (6)
- Tachycardia
- Abdominal discomfort or pain possibly accompanied by visible peristaltic waves in upper and middle abdomen
- Upper or epigastric abdominal distention
- Nausea and early, profuse vomiting (may contain fecal material, be orange brown)
- Obstipation (no passage of stool) or diarrhea if partial obstruction
- Metabolic alkalosis (due to obstruction high in small intestine causing loss of gastric HCl)- (not always present)
S/s of all bowel obstructions (5)
- Peristaltic waves
- Borborygmi (high pitched bowel sounds) – seen in early process w/ cramping as intestine tries to push obstruction
- Absent bowel sounds distal the obstruction
- Minimal tenderness and rigidity
- Pain aggravated by food or oral fluids
Signs of large bowel obstruction (6)
- Intermittent colicky lower abdominal cramping
- Lower abdominal distention
- Minimal or no vomiting
- Obstipation or ribbon-like stools
- Blood in stools
- Metabolic acidosis -(due to obstruction at end of small intestine and lower in intestinal tract leading to loss of alkaline fluids) - (not always present)
Diagnostics and labs for bowel obstruction (5)
- Abdominal CT/MRI scan
- Endoscopy (Sigmoidoscopy or Colonoscopy)
- Exploratory laparotomy (Ex-Lap)
- WBC - normal unless infarction, gangrene or strangulated
- Electrolytes (low Na, Cl, K; high hct and BUN in small bowel; no major imbalances in large bowel obstruction)
Management of bowel obstruction (8)
- NPO
- NGT to decompress the bowel
- IVF replacement b-c risk for f/e imbalance
- TPN if bowel nonfunctional
- Comfort/pain (Opioids can worsen so avoid if possible)
- Enema (hydrostatic enema for intussusception
- digital Impaction removal if lower colon (order needed to remove)
- Colectomy may be needed
Failure to rescue problems for Intestinal obstruction (4)
- Fecal Impaction
- Peritonitis (infection of peritoneal cavity)
- Septic shock
- Intra-abdominal pressure (Acute compartment syndrome)- esp if strangulated
NGT Decompression: Nursing Care (8)
- Monitor drainage and gastric output q4h
- Ensure NGT patency (function and irrigate w/ NS) q4h
- Verify tube placement: X-ray, pH strips q4h
- Maintain the patient on NPO status
- frequent mouth and nares care
- semi-Fowler’s position
- Secure tube to gown
- DO NOT USE TUBE FOR ORAL INTAKE
Risk factors for colon cancer (7)
- High-fat diet (Red meats)
- Low-fiber diet (High fiber diet = prevention)
- Family history of colorectal cancer
- History of Crohn’s, Ulcerative Colitis, H. Pylori, Irritable bowel syndrome
- smoking
- obesity and inactivity
- heavy alcohol use
Colorectal Cancer: Physical Assessment signs (7)
- Anemia
- Rectal bleeding
- Change in bowel habits (Constipation, Diarrhea, stool texture, stool size, melena)
- Vomiting
- Abdominal discomfort or fullness
- unintentional weight loss
- Abdominal mass (late finding)
Colorectal Cancer: Diagnostics (3)
- CBC (low hct/hgb = anemia)
- Imaging (CT, MRI)
- Tumor, nodes, metastasis classification (staging)
Colorectal Cancer Screening
Sigmoidoscopy -1
Colonoscopy - 4
Sigmoidoscopy
*Visualization and removal of lesions/polyps of the lower colon using a fiberoptic scope
Colonoscopy
*High sensitivity & specificity so definitive for colorectal cancer
*pre-cancerous polyps/lesion can be removed and biopsy done during procedure
*Start at 50 yrs if no family hx
* clear liquids prior to test (no red, purple, or orange dyes)
Double-contrast Barium Enema
Indication (2)
Procedure (3)
Nursing Care (3)
Indication: Colon cancer screening, differentiate UC and crohn’s disease
Procedure
*Examines the entire length of the bowel (detects half of all large polyps)
*Barium is swallowed as liquid or solid
* if abnormal, may need colonoscopy for suspected colon cancer
Nursing care
- Need to void afterwards for elimination of contrast dye
- NPO prior to procedure
- Expect light colored stools (barium is light chalk colored)
Colon Cancer Screening: Fecal Occult Blood test
Procedure (2)
Patient education (2)
Next steps
Procedure
- collected on card or in cup
- 2-3 separate stool samples needed on 3 consecutive days
Patient Education
- Avoid aspirin, vitamin C, iron, red meat for 48 hrs before test
- Avoid NSAIDs, corticosteroids, anticoagulants before test
Next steps
- if positive, need colonoscopy to diagnose b-c simply says GI bleeding present
Colostomy
What is it?
Indications (3)
Nursing care (4)
- removes the sigmoid colon, rectum, and anus through combined abdominal and perineal incisions
Indications: tumor, diverticulitis, bowel obstruction
Nursing Care
- NGT decompression until peristalsis returns post-op
- examine stoma, skin around stoma
- Assess the pouch system for proper fit and signs of leakage
- Assess for signs of complications (unusual bleeding OR ischemia/necrosis (dark red, purplish, or black color; dry stoma)
Stomas: Expected Findings (5)
- should be red pink, painless (black or purple = bad)
- Protrudes 3 cm from abdominal wall (prolapse if more and treat like evisceration)
- Functions in 2-3 days
- heals in 2 months
- Surrounding skin around should be intact, smooth, w/o redness or excoriation (no folliculitis or dermatitis)
Stomas: Patient education (4)
- Use barrier skin cream
- Empty pouch when 1/3 to 1/2 full
- Assess stoma and change wafer and pouch weekly (wafer 1/8th wider than stoma)
- Caution w/ high fiber foods b-c can cause gas and odor
Ulcerative Colitis: Drug Therapy
Aminosalicylates (5-ASA) – Sulfasalazine
Action
Patient education (3)
Action: metabolized by intestinal bacteria into 5-ASA which provides antiinflammatory effects and sulfapyridine
Patient education
* Take folic acid supplement b-c Sulfasalazine reduces its absorption
* Thiazide diuretic may be contraindicated
* Avoid if sulfa allergy
Ulcerative Colitis: Drug Therapy
Glucocorticoids (ex. prednisone, prednisolone, budesonide (preferred))
Use
Side effects (5 w/ long-term)
Use: antiinflammatory during acute flares
Side effects of long-term use: hyperglycemia, osteoporosis, PUD, increased infection risk, adrenal insufficiency
Ulcerative Colitis: Drug Therapy
Biologic response modifiers (BRMs) (ex. infliximab)
Action
Side effect
Action: synergistic effect w/ steroids via igG monoclonal antibody to reduce activity of tumor necrosis factor (TNF) to decrease inflammation
Side effects: immunosuppression (pt should report any s/s of infection and avoid large crowds)
Ulcerative Colitis: Drug Therapy
Antidiarrheal drugs (ex. diphenoxylate hydrochloride, atropine sulfate, loperamide)
Use
Side effect
- Use: symptomatic management w/ caution b-c can have opposite effect
- Side effect: toxic megacolon (massive dilation of colon and colonic ileus leading to gangrene and peritonitis)
Ulcerative Colitis: Nutrition Therapy
What to do (2)
What to avoid (4)
- If severe, NPO and then TPN if severely ill and malnourished
- If less severe, drink elemental formulas (have components which reduce bowel stimulation)
Avoid
- caffeine and alcohol (may cause diarrhea and cramping)
- raw veggies and high fiber (can cause GI symptoms)
- lactose containing foods (poorly tolerated)
- GI stimulants ( carbonated beverages, pepper, nuts, corn, dried fruits, smoking)
Complications of Ulcerative Colitis
- Acute (6)
- Long-term (3)
Acute
- Abscesses in ulcers (pockets of infection)
- Peritonitis
- Bowel Perforation (stool goes in abdominal cavity)
- Bowel Obstructions due to edema, hyperemia, and mucosal thickening
- Toxic megacolon (massive dilation of colon leads to colonic ileus)
- GI Bleeds
Long-term
- Malabsorption leads to anemia and malnutrition
- Pernicious anemia (B12 deficiency)
- Colorectal Cancer (if > 10 yrs of UC)
Signs of GI Bleeding (6)
- Hematochezia (bright red stools) – lower GI bleed
- Melena (black, tarry, or dark red sticky stools)
- Upper GI Bleed (Dark blood)
- shock (low hct/hgb, low BP, high HR, weak pulses)
- dizziness, confusion, syncope
- vertigo
Peptic Ulcer Disease
What is it?
Transmission
- Erosion of the mucosa of the stomach, esophagus or duodenum due to H. pylori neutralizing stomach acidity then exposing epithelium to gastric acid
Transmission
- via oral-oral OR fecal-oral route (water, food, saliva)
Signs of stomach perforation (3)
- sudden sharp mid-epigastric pain spreads over abdomen (often radiates to right shoulder
- peritonitis (infection w/ tender, rigid, boardlike abdomen AND rebound tenderness)- fetal position for relief
- Shock manifestations (hypotension, tachycardia, dizziness, confusion)
Signs of PUD
General (5)
Failure to rescue (3)
- Dyspepsia (sharp, burning or gnawing pain at epigastric or back; heartburn, NV)
- GI bleedings (melena and hematemesis)
- Sensation of abdominal pressure or fullness or hunger
- Weight loss
- pernicious anemia (r/t decreased intrinsic factor)
Failure to rescue
- Perforation
- hemorrhage
- pyloric obstruction (s/s metabolic alkalosis, NV due to stasis and gastric dilation)
Drug Therapy for PUD
Antacids (ex. Aluminum hydroxide and Magnesium hydroxide)
Actions
Precaution
Side effects (2)
Nursing Care (2)
Action: increase pH of gastric contents
Precautions
- CKD and CHF increase chance of toxicity w/ magnesium hydroxide
Side effects
- diarrhea w/ magnesium
- constipation w/ aluminum
Nursing Care
- give 1-2 hrs after meals and at bedtime
- give other drugs 2 hrs before or after
Histamine blockers (ex. Famotidine, Ranitidine)
Use (2)
Action
Nursing Care (2)
Use: PUD, heartburn,
Action: decrease gastric acid secretions via blocking H2 receptors in stomach
Nursing Care
- give w/ or w/o food
- give at bedtime
Drug Therapy for PUD
Proton pump inhibitors (ex. Omeprazole, Pantoprazole, Esomeprazole)
Action
Side effects (3)
Nursing Care (3)
Action: decreases production of gastric acid
Side effects (long term): fractures, pneumonia, C. diff
Nursing Care
- give 30 minutes before meals unless rabeprazole (for duodenal ulcers so give prior to morning meal)
- do not give IV PPIs w/ other drugs
- taper to prevent rebound activation w/ withdrawal
Antibiotics used for H. pylori (4)
- Clarithromycin (monitor BUN)
- Amoxicillin (monitor for NVD)
- Tetracycline (take w/o meals; avoid dairy products and sunlight)
- metronidazole (monitor for Nausea; avoid alcohol b-c disulfiram-like reaction
General Effects of HIV on host (2)
- high viral load (>200) leads to infections
- low T cell/CD4 count (<800) and poor functioning T-cells leads to opportunistic infections, leukopenia, lymphocytopenia
cART therapy: Immune reconstitution inflammatory syndrome (IRIS)
Cause (2)
S/s
Treatment
Cause
- Seen when CD4+ T-cell count rises, and immunity normalizes then becomes exaggerated
- Result of T-cell recognizing opportunistic infections (esp TB) and sounding alarm about them
s/s: inflammatory reaction (high fever, chills, maybe worsened disease)
Treatment: short-term therapy w/ corticosteroids (Ideally treat Opportunistic infections prior to starting cART)
CART therapy in HIV
Therapeutic Effect - 2
Preparation - 1
Therapeutic Effect
- controls viral replication to reduce viral load in 4 weeks and increases T-cell count
- U=U (undetectable viral load (< 200 for > 6 months) = untransmittable via sex)
Preparation
- genosure resistance paneling (determine hypersensitivity to drugs to determine what to use
CART therapy in HIV
Patient Education (5)
- Do not stop taking drugs or change therapy once viral load decreases b-c drugs are not a cure
- Must take drugs correctly 90% of time (9 out of 10 doses on time and correct) - Do not miss, delay, or take lower than prescribed dose
- Drug resistance r/t missed doses causing new resistant viral particles (Once resistant to a drug, that drug no longer able to be used b-c resistant virus is archived indefinitely in body)
- many drugs cause liver toxicity (report to HCP any jaundice, NV, abdominal pain)
- If pregnant, check w/ HCP because some drugs cause birth defects but other drugs can help reduce transmission to baby
S/s of symptomatic HIV (9)
- persistent fever
- sore throat
- rash
- night sweats, chills
- diarrhea
- weight loss
- fatigue
- headache, muscle aches
- lymphadenopathy
Stages of HIV (5)
Initial Exposure
Primary HIV (acute): flu-like symptoms within 4 weeks; antibodies in 1-6 months
Asymptomatic HIV (seropositive): infectious but no evidence except positive HIV antibody test
Symptomatic HIV: can be 10 yrs after initial exposure
AIDS: diagnosis made if T-cell count is ever < 200 OR less than 14% OR opportunistic infection (diagnosis remains forever)
HIV testing
3 generations of ELISA
Notes (3)
ELISA
1st generation (1980s): IgG
2nd generation (1991): IgG
3rd generation (1992): IgM & IgG
Note
* 1st-3rd gen need western blot after if positive b-c can indicate influenza as well
* takes 3 months for antibodies to appear after antigen
* takes 14-21 days for antibody to be detected and then 7 days for western blot to confirm
HIV testing: 4th Generation Testing (2010)
Process (3)
Timing (2)
Process
- Detects ANTIGEN & ANTIBODY via antigen/antibody immunoassay
- If positive, use antibody differentiation immunoassay
- If antibody differentiation immunoassay is negative or indeterminate, use nucleic acid test to determine if acute HIV infection (RNA present)
Timing
- detects HIV-IgM and IgG antibodies (positive in 21 days)
- detects presence of p24 antigen (HIV capsid protein which is positive in 14 days)
HIV Transmission
Routes (3)
- Parenteral (needle sharing; contaminated equipment w/ blood)
- Perinatal (vertical; from placenta due to contact w/ maternal blood and body fluids or breast milk)
- sexual (genital, oral or anal b-c exposure to mucous membranes) - esp. anal or male-to-female
Secondary prevention: HIV (3)
- one time screening for all adults b/w 15-65
- annual screening for adults at high risk for HIV (man/man sex, nonmonogamus, parenteral drug users, relationships w/one HIV positive and one HIV negative partner; anyone diagnosed with STIs in the past 6 months)
- prenatal screening for pregnant people
Primary Prevention: HIV (5)
- If drug user, clean used needle w/ bleach for 30-60 seconds OR partake in needle-exchange program
- Abstinence or mutually monogamous sex w/ noninfected partner
- Wear dental dam
- Use Water based lube w/ condom
- Latex gloves for finger or hand contact w/ vagina or rectum
Pre Exposure Prophylaxis (PrEP) – ex. Truvada (tenofovir/emtricitabine) AND Discovy (emtricitabine/tenofovir)
Indication
Routine (2)
Concern
Testing (3)
Indication: use of HIV Antiretroviral drugs by HIV-uninfected adult to prevent infection
Routine
- once daily w/ prescription
- Protection starts after 7 days of consistent dosing (can miss one and be okay; if miss > 2, need to wait 7 days for protection again)
Concern: Black box warning for severe acute exacerbation of hep B
Testing
* Blood and urine testing plus liver and kidney function (test kidney q3 months)
* other STI tests, hepatitis test
* 4th gen HIV antigen/antibody testing to ensure HIV negative b-c not for HIV positive
Recommendations for Preventing HIV Transmission by Healthcare Workers (3)
- Standard Precautions (gloves for body fluids)
- If sharps related; first wash wound for 1 full minute then contact employee health
- If you perform exposure-prone procedures, know your HIV antibody status.
Postexposure Prophylaxis (PEP)
Indication (2)
Routine (2)
Testing (2)
Indication: occupational exposure (sharps, body fluids of HIV positive pt w/ blood, broken skin or mucus membranes of HCP), nonoccupational exposure (consensual sexual exposure w/ person of unknown HIV status OR sexual assault)
Routine
- 3 drug regimen within 2-36 hrs of exposure for 28 days OR until HIV status negative
- no prescription needed
Testing
- Periodic HIV testing at 1, 3, and 6 months
- CBC, electrolytes, creatinine tests done 2 weeks after starting cART
HIV Complications: Neurological (4)
Neurological (HIV-associated neurocognitive disorder (HAND) and HIV-associated dementia complex (HADC)
- s/s cognitive, motor, and behavioral impairments (confusion to dementia)
- peripheral neuropathy (paresthesia and burning sensations, reduced sensory perception, pain, gait changes)
- myopathy (leg weakness, ataxia, and muscle pain)
- increased ICP (pupil size or reactivity change
HIV Complications
Cardiovascular
Skin (3)
Kidney
Cardiovascular: Disordered fat metabolism (elevated triglycerides and cholesterol) and diabetes increase risk for hypertension and atherosclerosis
Skin changes
* dry, itchy, irritated skin
* folliculitis, eczema, psoriasis possible
* petechiae or bleeding gums if low platelets
Kidney changes (minor glomerular injury to AKI to CKD or HIV-associated nephropathy (HIVAN)
HIV complications: Endocrine (5)
AIDS wasting syndrome (s/s diarrhea, malabsorption, anorexia, oral and esophageal lesions)
Gonadal dysfunction (Low testosterone in men and Irregular menses in women)
Body shape changes
* Lipodystrophy w/ old cART (s/s buffalo hump, large belly fat)
* Lipoatrophy (s/s wasted arms, face, legs; sunken cheeks)
Adrenal insufficiency – life-threatening (s/s fatigue, weight loss, NV, low BP, electrolyte disturbance)
Diabetes
HIV complications: malignancies (5)
Kaposi’s sarcoma
* r/t coinfection of HIV and human herpesvirus 8
* S/s: small, purplish-brown, raised lesions on skin and mucous membranes (mouth, throat, intestinal tract, lungs, lymph nodes) that are not painful or itchy
* Nursing care: assess #, size, location, if intact
Non-Hodgkin’s or Hodgkin’s lymphoma
* s/s: swollen lymph nodes, weight loss, fever, night sweats
Invasive cervical carcinoma and anal cancer
* r/t HPV leading to cervical and anal dysplasia
* Prevention: Cervical Pap testing q6 months or anal Pap test
Lung cancer
GI cancer
HIV: Viral load testing
Process (3)
Results (3)
Concern
Process
- Measures actual amount of HIV viral RNA particles in 1 mL of blood to measure therapy effectiveness
- positive within 10 days of exposure
- takes 14 hrs for test to process
Results
* Uninfected adult: no viral load
* Positive load: as little as 20 particles/mL or > 1 million particles/mL
* Higher the load, higher risk of transmission
Concern: some immune systems may suppress viral replication and cause false low; so 4th gen testing needed alongside viral load testing